Salerno L, Di Fede G, Pepe S, Iacò V
Cattedra di Fisiopatologia Clinica, Università degli Studi di Palerma.
Clin Ter. 1995 Dec;146(12):775-9.
After a short introduction about the current role of digitalis in the treatment of the supraventrical arrhythmias and about the factors that make often problematic the achievement of an optimal posology of the drug, the results relative to more recent 340 digoxinaemia determinations in patients of Policlinico in Palermo or in outpatients are presented. Just the 43.8% of the patients had a digoxinaemia value in the range considered therapeutic; just 45 patients (32.1%), out of the 140 in which the digoxinaemia had been monitored for, at least, 5 days, were in the therapeutic range at the first determination; the 47.8% of the patients were underdosed and the 38.8% of them showed higher values than the therapeutic range. Determination 5 or more days later showed digoxinaemia values in the therapeutic range in 112 patients (80%). According to the reported results, it may be presumed that the posology correction effectuated by the physician on these patients might have been driven by the digoxinaemia values, whose determination must be considered an unavoidable guide to the digitalis treatment.
在简短介绍了洋地黄目前在治疗室上性心律失常中的作用以及导致药物最佳剂量确定常常出现问题的因素之后,展示了巴勒莫综合医院患者或门诊患者中最近340次地高辛血药浓度测定的结果。仅有43.8%的患者地高辛血药浓度值处于治疗范围内;在140例至少监测了5天地高辛血药浓度的患者中,仅有45例(32.1%)在首次测定时处于治疗范围内;47.8%的患者用药剂量不足,其中38.8%的患者血药浓度值高于治疗范围。5天或更久之后的测定显示,112例患者(80%)的地高辛血药浓度值处于治疗范围内。根据报告结果,可以推测医生对这些患者进行的剂量调整可能是由地高辛血药浓度值驱动的,地高辛血药浓度的测定必须被视为洋地黄治疗不可避免的指导依据。